| Strategies to overcome DC dysregulation in the tumor microenvironment G Mestrallet, K Sone, N Bhardwaj Frontiers in Immunology 13, 980709, 2022 | 28 | 2022 |
| Anti‐HIV‐1 antibodies trigger non‐lytic complement deposition on infected cells J Dufloo, F Guivel‐Benhassine, J Buchrieser, V Lorin, L Grzelak, ... EMBO reports 21 (2), e49351, 2020 | 28 | 2020 |
| Immune escape and resistance to immunotherapy in mismatch repair deficient tumors G Mestrallet, M Brown, CC Bozkus, N Bhardwaj Frontiers in Immunology 14, 1210164, 2023 | 18 | 2023 |
| Skin immunity and tolerance: focus on epidermal keratinocytes expressing HLA-G G Mestrallet, N Rouas-Freiss, J LeMaoult, NO Fortunel, MT Martin Frontiers in immunology 12, 772516, 2021 | 18 | 2021 |
| Methods for establishing a renal cell carcinoma tumor spheroid model with immune infiltration for immunotherapeutic studies L Lugand, G Mestrallet, R Laboureur, C Dumont, F Bouhidel, M Djouadou, ... Frontiers in Oncology 12, 898732, 2022 | 10 | 2022 |
| Human Keratinocytes Inhibit CD4+ T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints G Mestrallet, F Auvré, C Schenowitz, ED Carosella, J LeMaoult, MT Martin, ... Cells 10 (6), 1438, 2021 | 10 | 2021 |
| Software development for severe burn diagnosis and autologous skin substitute production G Mestrallet Computer Methods and Programs in Biomedicine Update 2, 100069, 2022 | 5 | 2022 |
| Immunosuppressive properties of epidermal keratinocytes differ according to their immaturity status G Mestrallet, ED Carosella, MT Martin, N Rouas-Freiss, NO Fortunel, ... Frontiers in Immunology 13, 2022 | 3 | 2022 |
| Predicting Immunotherapy Outcomes in Glioblastoma Patients through Machine Learning G Mestrallet Cancers 16 (2), 408, 2024 | 2 | 2024 |
| Software development to estimate herd profitability according to nutrition parameters. G Mestrallet agriRxiv, 20230009899, 2023 | 1 | 2023 |
| Prediction of Glioma Resistance to Immune Checkpoint Inhibitors Based on Mutation Profile G Mestrallet Neuroglia 5 (2), 145-154, 2024 | | 2024 |
| Overcoming immune resistance in DNA mismatch repair deficient tumors G Mestrallet Cancer Research 83 (7_Supplement), 6652-6652, 2023 | | 2023 |
| Immune response and resistance of clear cell renal cell carcinoma patients following immune checkpoint blockade. G Mestrallet bioRxiv, 2023.10. 05.561140, 2023 | | 2023 |
| Predicting response and resistance to immune checkpoint blockade and surgery in melanoma patients. G Mestrallet medRxiv, 2023.10. 05.23296626, 2023 | | 2023 |
| Enhancing immunotherapy outcomes in glioblastoma through predictive machine learning. G Mestrallet medRxiv, 2023.10. 05.23296617, 2023 | | 2023 |
| Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies L Lugand, G Mestrallet, R Laboureur, C Dumont, F Bouhidel, M Djouadou, ... Frontiers in Oncology 12, 898732, 2022 | | 2022 |
| Propriétés immunitaires des kératinocytes humains et de leurs précurseurs G Mestrallet Frontiers in Immunology, 2021 | | 2021 |
| Software development for autologous skin substitute production G Mestrallet medRxiv, 2021.04. 16.21255595, 2021 | | 2021 |
| Human Keratinocytes Inhibit CD4+ T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints. Cells 2021, 10, 1438 G Mestrallet, F Auvré, C Schenowitz, ED Carosella, J LeMaoult, MT Martin, ... Frontiers in Immunology, 2021 | | 2021 |
| Commentary for PracticeUpdate Gastroenterology G Mestrallet, N Bhardwaj | | |
